| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.009 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |